The latest proactive video is definitely worth watching.
LC Suggest that they have all the data, are now going to review the Her Vax data, including blinded radiology review, which will help independently verify progression free survival status for each cohort. I suspect IMU will then look at an FDA submission for Her Vax (She says as much in the interview).
This would be a logical/ necessary step in de-risking any partnership/pharma deal which may evolve beyond this point.
It is also implied in the commentary that, given there are such a small number of patients in the trial, a significant difference in PFS between "treatment" ie HerVax/Conventional treatment versus conventional treatment alone exists. Otherwise smaller differences would require a higher "powered' study, ie greater number of patients to see smaller differences.
IMHO K
The latest proactive video is definitely worth watching.LC...
-
- There are more pages in this discussion • 13,911 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.001(1.79%) |
Mkt cap ! $411.5M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.5¢ | $85.31K | 1.545M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 3146255 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 1479940 | 8 |
View Market Depth
| Last trade - 10.22am 25/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |